Daily non-political popular news in brief.

Malaria-infected mice cured by 1 dose of new drug

Johns Hopkins researchers have cured malaria-infected mice with single shots of a new series of potent, long lasting synthetic drugs modeled on an ancient Chinese herbal folk remedy.

Read more »

Keywords: malaria-infected, mice, cured, dose, drug, malaria, infected

« Previous | Next »

Similar news on "Malaria-infected mice cured by 1 dose of new drug":

1. Human antibodies protect mice from avian flu
   05-28-2007 · EurekAlert!
   An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus.
   Similar news · Read more »
   
2. For treating malaria, less drugs may be best drugs
   11-26-2007 · EurekAlert!
   The current dosage of drugs used in treating malaria may be helping the parasites become resistant to the drugs faster, without improving the long-term outcome in patients. According to evolutionary biologists, studies using mice suggest that the optimal use of the drugs might slow the spread of drug resistance while making the patient just as healthy.
   Similar news · Read more »
   
3. Male contraception: One door opens, another closes
   11-07-2006 · EurekAlert!
   Researchers have announced a breakthrough on a non-hormonal compound known as Adjudin. When injected as an attachment to a modified hormone that seeks out the testes, a low dose is a safe and effective contraceptive in rats. However, another promising drug, miglustat, has failed to make the leap from mice to men.
   Similar news · Read more »
   
4. Low dose of serotonin-acting chemical improves blood sugar tolerance
   11-06-2007 · EurekAlert!
   An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press. Importantly, the researchers found, those effects of the drug occurred at a low dose that had no influence on feeding behavior, body weight, activity level, or energy expenditure.
   Similar news · Read more »
   
5. Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows
   02-25-2007 · EurekAlert!
   A once-a-day, short-term treatment with a drug compound substantially improved learning and memory in mice with Down syndrome symptoms, say researchers at the Stanford University School of Medicine and Lucile Packard Children’s Hospital.
   Similar news · Read more »
   
6. MIT researchers reverse symptoms in mice of leading inherited cause of mental retardation
   06-25-2007 · EurekAlert!
   Researchers at the Picower Institute at MIT have, for the first time, reversed symptoms of mental retardation and autism in mice. The study may lead to new drug therapies for a leading inherited cause of mental retardation (Fragile X Syndrome) and some types of autism.
   Similar news · Read more »
   
7. Preclinical study suggests organ-transplant drug may aid in lupus fight
   08-15-2007 · UT Southwestern Medical Center
   A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.
   Similar news · Read more »
   
8. Shire investigational drug (SPD465) designed to reduce ADHD symptoms for up to 16 hours
   10-31-2006 · EurekAlert!
   Shire announced that the investigational amphetamine compound SPD465 (triple-bead mixed amphetamine salts) improved Attention-Deficit/Hyperactivity Disorder symptoms in adults for up to 16 hours post-dose and had a generally well-tolerated safety profile consistent with currently marketed amphetamine products, according to the results of two phase 2 trials released at a meeting of child and adolescent psychiatrists in San Diego, California.
   Similar news · Read more »
   
9. HIV drug resistance risk in mothers reduced by combination of common drugs
   11-09-2007 · EurekAlert!
   Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.
   Similar news · Read more »
   
10. Stress triggers relapse in meth abuse, OHSU study finds
    10-18-2006 · EurekAlert!
    Oregon Health & Science University research showing stress triggers relapse of methamphetamine abuse in mice could be a step toward developing a drug to curb this frustrating obstacle to recovery. Results of the study not only validate earlier studies on the effects of stress on drug relapse in humans, they also show a compound researchers used to mimic metabolic changes that occur during stress creates a useful model for studying this effect in the laboratory.
    Similar news · Read more »